Periodontal Therapeutics Market Size, Growth Report 2032

Periodontal Therapeutics Market - By Product (Local Antibiotic Therapy, Systemic Antibiotic Therapy), Type (Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease), Distribution Channel– Global Forecast (2024 – 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Growing prevalence of periodontal diseases

3.2.1.2&nbsp;&nbsp;&nbsp; Increasing awareness about oral health

3.2.1.3&nbsp;&nbsp;&nbsp; Rising geriatric population

3.2.1.4&nbsp;&nbsp;&nbsp; Technological advancements in dentistry

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Limited awareness and education for oral health

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent regulatory policies

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Technological landscape

3.6.1&nbsp;&nbsp;&nbsp; Core technologies

3.6.2&nbsp;&nbsp;&nbsp; Adjacent technologies

3.7&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Local antibiotic therapy

5.2.1&nbsp;&nbsp;&nbsp; Minocycline hydrochloride

5.2.2&nbsp;&nbsp;&nbsp; Doxycycline hyclate

5.2.3&nbsp;&nbsp;&nbsp; Chlorhexidine gluconate

5.2.4&nbsp;&nbsp;&nbsp; Metronidazole benzoate

5.2.5&nbsp;&nbsp;&nbsp; Tetracycline hydrochloride

5.3&nbsp;&nbsp;&nbsp; Systemic antibiotic therapy

5.3.1&nbsp;&nbsp;&nbsp; Minocycline hydrochloride

5.3.2&nbsp;&nbsp;&nbsp; Doxycycline hyclate

5.3.3&nbsp;&nbsp;&nbsp; Metronidazole benzoate

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Type, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Gingivitis

6.3&nbsp;&nbsp;&nbsp; Chronic periodontal disease

6.4&nbsp;&nbsp;&nbsp; Aggressive periodontal disease

6.5&nbsp;&nbsp;&nbsp; Necrotizing periodontal disease

6.6&nbsp;&nbsp;&nbsp; Other types

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Distribution Channel, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospital pharmacies

7.3&nbsp;&nbsp;&nbsp; Retail pharmacies

7.4&nbsp;&nbsp;&nbsp; Drug stores

7.5&nbsp;&nbsp;&nbsp; E-commerce

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Netherlands

8.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Align Technology, Inc.

9.2&nbsp;&nbsp;&nbsp; Bausch Health Companies Inc.

9.3&nbsp;&nbsp;&nbsp; Cadila Healthcare Ltd.

9.4&nbsp;&nbsp;&nbsp; Colgate-Palmolive Company

9.5&nbsp;&nbsp;&nbsp; Danaher Corporation

9.6&nbsp;&nbsp;&nbsp; Den-Mat Holdings LLC

9.7&nbsp;&nbsp;&nbsp; Dentsply Sirona

9.8&nbsp;&nbsp;&nbsp; Dexcel Pharma Technologies Ltd.

9.9&nbsp;&nbsp;&nbsp; GlaxoSmithKline plc

9.10&nbsp;&nbsp;&nbsp; Henry Schein, Inc.

9.11&nbsp;&nbsp;&nbsp; Hoffmann-La Roche Ltd.

9.12&nbsp;&nbsp;&nbsp; Johnson &amp; Johnson Services, Inc.

9.13&nbsp;&nbsp;&nbsp; Kaken Pharmaceutical Co., Ltd.

9.14&nbsp;&nbsp;&nbsp; Pfizer Inc.

9.15&nbsp;&nbsp;&nbsp; Procter &amp; Gamble Co.

9.16&nbsp;&nbsp;&nbsp; Straumann Holding AG

9.17&nbsp;&nbsp;&nbsp; Sunstar Suisse SA

9.18&nbsp;&nbsp;&nbsp; Teva Pharmaceutical Industries Ltd.

9.19&nbsp;&nbsp;&nbsp; Zimmer Biomet Holdings, Inc.

9.20&nbsp;&nbsp;&nbsp; 3M Company 
&nbsp;

Periodontal Therapeutics Market

Get a free sample of this report